FDA 510(k)

TraumaCad Mobile Release 2.0

K-Number: K160001 · 2016-02-12

Decision Date2016-02-12

Product CodeLLZ

Advisory CommitteeRA

DecisionSubstantially Equivalent

Device Summary

TraumaCad Mobile Release 2.0 is the device name listed in this FDA 510(k) record. The listed applicant is Voyant Health, Ltd.. It received FDA 510(k) clearance on 2016-02-12 under 510(k) number K160001. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TraumaCad Mobile Release 2.0?

TraumaCad Mobile Release 2.0 is a medical device that received FDA 510(k) clearance on 2016-02-12. The listed applicant is Voyant Health, Ltd.. The 510(k) number is K160001.

When did TraumaCad Mobile Release 2.0 receive FDA 510(k) clearance?

TraumaCad Mobile Release 2.0 received FDA 510(k) clearance on 2016-02-12, under 510(k) number K160001.

Who is the listed applicant for TraumaCad Mobile Release 2.0?

The FDA 510(k) record lists Voyant Health, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TraumaCad Mobile Release 2.0?

The FDA product code for TraumaCad Mobile Release 2.0 is LLZ.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262449AdvaViewADVAHEALTH SOLUTIONS, LLC K261916NeuroQuant PETCortechs Labs, Inc.K260936RadioViewAINeurocareai, Inc. (Dba Savelife.Ai)K260588Cleerly LABSCleerly, Inc.K262462TheraSphere 360™ Y-90 Management PlatformBoston Scientific Corporation K262143ImageGrid StreamVueCandelis, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.